Engineers Gate Manager’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-16,400
Closed -$70K 2239
2021
Q1
$70K Buy
+16,400
New +$90.4K ﹤0.01% 1731
2020
Q3
Sell
-52,700
Closed -$225K 2130
2020
Q2
$225K Buy
52,700
+25,800
+96% +$157K 0.01% 1384
2020
Q1
$113K Buy
+26,900
New +$170K 0.01% 1390

Other funds holding LJPC

Engineers Gate Manager's LJPC Position: Q2 2021 in Review

Engineers Gate Manager sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2021, closing a stake of 16,400 shares — an estimated $70K sold.

Engineers Gate Manager first reported a position in LJPC in Q1 2020 and held it in 3 quarters. The position peaked at $225K in Q2 2020. 62 funds tracked by Wall St. Rank hold LJPC as of Q2 2021.

  • Engineers Gate Manager reported no remaining La Jolla Pharmaceutical Company position as of Q2 2021 after selling out during the quarter.
  • Engineers Gate Manager sold 16,400 La Jolla Pharmaceutical Company shares in Q2 2021, an estimated $70K.
  • Engineers Gate Manager first reported a position in La Jolla Pharmaceutical Company in Q1 2020 and held it in 3 quarters.
  • Engineers Gate Manager's La Jolla Pharmaceutical Company position peaked at $225K in Q2 2020.
  • 62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2021.

Based on Engineers Gate Manager's 13F filing for Q2 2021, filed 16 Aug 2021.